R

Prometheus Bio (RXDX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Prometheus Bio (RXDX)

Ignyta, Inc. is a biotechnology company. The Company is focused on precision medicine in oncology. The Company is pursuing an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. The Company's pipeline incl... Read more

  • USD107.56
  • USD111.59
  • USD107.25
  • USD129.60
  • -8.40%
  • 7M
  • 355.60k
  • 517.19k
  • 5.1B
  • 21.50
  • 171.20%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.